An improved protocol for generation and characterization of human-induced pluripotent stem cell-derived retinal pigment epithelium cells

STAR Protoc. 2022 Nov 4;3(4):101803. doi: 10.1016/j.xpro.2022.101803. eCollection 2022 Dec 16.

Abstract

We present an optimized protocol for guided differentiation of retinal pigment epithelium (RPE) cells from human-induced pluripotent stem cells (iPSC). De novo-generated RPE cells are mature, polarized, and mimic the cellular and molecular profile of primary RPE; they are also suitable for in vivo cell transplantation studies. The protocol includes an enrichment step, making it useful for large-scale GMP manufacturing. RPE cells produced following this protocol are appropriate for cell replacement therapy for macular degeneration and disease modeling. For complete details on the use and execution of this protocol, please refer to Surendran et al. (2021).

Keywords: Cell culture; Cell differentiation; Health sciences; Stem cells.

MeSH terms

  • Cell Differentiation
  • Cell- and Tissue-Based Therapy
  • Humans
  • Induced Pluripotent Stem Cells*
  • Macular Degeneration* / therapy
  • Retinal Pigment Epithelium